menkes patient portal

What is the Menkes disease clinic?

Co-payments are payable at the time of service. Forms of payment accepted at The Menkes Clinic & Surgery Center include Visa, MasterCard, American Express, cash, and personal checks. You can also make a payment through our patient portal by clicking the 'Make a Payment' button. We also recommend Alphaeon Credit or CareCredit as a payment option.

Can a male with Menkes disease pass it to his son?

PatientPortal

What are the signs and symptoms of Menkes syndrome?

Mar 27, 2019 · Definition. Menkes disease is caused by a defective gene named ATPTA1 that regulates the metabolism of copper in the body. The disease primarily affects male infants. Copper accumulates at abnormally low levels in the liver and brain, but at higher than normal levels in the kidney and intestinal lining.

What is the prognosis of Menkes disease?

Menkes Disease - PAN Foundation. The PAN Foundation will be closed from 3-4:30 pm ET on Wednesday, April 6, 2022 for team training. Please use our portals – available 24/7 – to apply for assistance or manage your grant.

How is Menkes disease diagnosed?

Menkes disease is typically diagnosed based on the clinical features, medical examination, and genetic testing for alterations in the ATP7A gene . Other types of tests that may be helpful include analysis of catecholamines (chemicals that are sensitive to copper) and copper levels in the blood. [2]

What is Menkes disease?

Menkes disease (MD) is an inherited condition that impacts the way the body processes copper levels in the body. MD primarily affects the nervous system and connective tissue with symptoms that tend to get worse over time. Symptoms of MD usually appear within the first few months of life and include sparse, kinky hair;

What is MD in children?

MD is caused by alterations ( mutations) in the ATP7A gene and is inherited in an X-linked recessive pattern. MD mainly affects boys. Early treatment with copper may improve the long-term outcome in some children with this disease. [1] [2] Last updated: 3/30/2020.

How many babies are born with Menkes disease?

It is thought that approximately 1/100,000 – 1/300,000 babies are born with Menkes disease in most parts of the world. This incidence may be higher in Australia. [1] [2] [4]

What is the HPO database?

People with the same disease may not have all the symptoms listed. This information comes from a database called the Human Phenotype Ontology (HPO) . The HPO collects information on symptoms that have been described in medical resources.

Why is research important?

Research helps us better understand diseases and can lead to advances in diagnosis and treatment. This section provides resources to help you learn about medical research and ways to get involved.

What are the symptoms of MD?

Additional features may include low muscle tone ( hypotonia ), sagging facial features, and developmental and intellectual disability. Most children with MD have severe symptoms that lead to death at an early age. Oc cipital horn syndrome is a less severe form of MD that begins in early to middle childhood.

What causes menkes disease?

Menkes disease is caused by a defective gene named ATPTA1 that regulates the metabolism of copper in the body. The disease primarily affects male infants. Copper accumulates at abnormally low levels in the liver and brain, but at higher than normal levels in the kidney and intestinal lining. Affected infants may be born prematurely, but appear healthy at birth and develop normally for 6 to 8 weeks. Then symptoms begin, including floppy muscle tone, seizures, and failure to thrive. Menkes disease is also characterized by subnormal body temperature and strikingly peculiar hair, which is kinky, colorless or steel-colored, and breaks easily. There is often extensive neurodegeneration in the gray matter of the brain. Arteries in the brain may be twisted with frayed and split inner walls. This can lead to rupture or blockage of the arteries. Weakened bones (osteoporosis) may result in fractur...

Is Menkes disease early detection?

Since newborn screening for this disorder is not available, and early detection is infrequent because the clinical signs of Menkes disease are subtle in the beginning, the disease is rarely treated early enough to make a significant difference. The prognosis for babies with Menkes disease is poor.

800-538-9552

To create ant then access the MHS GENESIS Patient Portal, visit https://patient.mhsgenesis.health.mil

What are the chief benefits of MHS GENESIS?

MHS GENESIS is the first Department of Defense-wide electronic health record to be used by all military treatment facilities. By the time that MHS GENESIS is fully implemented throughout all of the DoD, patients will be able to receive care from any military treatment facility knowing that their health records will follow them.

How is MHS GENESIS different from CAL MED's current electronic health record systems?

Like all Army military treatment facilities, CAL MED currently uses several electronic health record systems for inpatient records, outpatient records, emergency room records, and other areas of care. While care teams can view patients' records in the different systems, this requires extra time to navigate all of the records.

What will I notice about what's new with MHS GENESIS?

The primary difference that patients will notice is the Patient Portal. While receiving care at MTFs which use MHS GENESIS, patients will no longer use RelayHealth and Tricare Online except for limited functions, such as requesting new providers.

When will I be able to start using the MHS GENESIS Patient Portal?

While patients may be able to log on to the Patient Portal and explore it during the weeks leading up to the transition to MHS GENESIS, the Patient Portal will not be active until September 7, 2019.

When patients move, will their new military treatment facilities be using MHS GENESIS?

The Department of Defense has a multi-year plan for all military treatment facilities to transition to MHS GENESIS. CAL MED is in the second wave of military treatment facility to transition to MHS GENESIS.